SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-026440
Filing Date
2022-07-20
Accepted
2022-07-20 09:20:27
Documents
12
Period of Report
2022-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20004764x2_8k.htm   iXBRL 8-K 20684
  Complete submission text file 0001140361-22-026440.txt   155966

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inva-20220720.xsd EX-101.SCH 3853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20220720_lab.xml EX-101.LAB 22546
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20220720_pre.xml EX-101.PRE 16036
6 EXTRACTED XBRL INSTANCE DOCUMENT ny20004764x2_8k_htm.xml XML 4227
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 221092966
SIC: 2834 Pharmaceutical Preparations